,,

Yuki Umemori1, Koichi Handa1, Saki Yoshimura1

  • 1DMPK Research Department, Teijin Institute for Bio-Medical Research, TEIJIN PHARMA LIMITED, 4-3-2 Asahigaoka, Hino-shi, Tokyo 191-8512, Japan.

Biomolecules
|May 24, 2024
PubMed
概括

开发一种新的计算模型可以通过分析共价结合风险来预测药物诱导的肝损伤 (DILI). 这种机器学习方法改进了评估活性代谢物的传统方法,有助于药物安全性评估.